Panhellenic Association of Pharmaceutical Industry holds annual assembly

The Panhellenic Association of Pharmaceutical Industry (PEF) held its Annual General Assembly on October 19 to discuss strategic priorities for the 2027–2030 period. The assembly focused on strengthening Greece's domestic pharmaceutical production base to ensure national drug adequacy, economic growth, and public health security.

Key attendees included the Minister of National Economy and Finance, Kyriakos Pierrakakis, and the Minister of Development, Takis Theodorikakos. Discussions emphasized the need for a stable and predictable regulatory framework to encourage investment and long-term sustainability. PEF President Theodoros Tryfon noted that enhancing the industry requires competitive energy costs, strong investment incentives, and a stable regulatory environment to facilitate technological upgrades and cleaner production.

The association highlighted that supporting the domestic pharmaceutical industry is a strategic investment in economic resilience and the security of the healthcare system, contributing significantly to employment and exports.